What Medpace Holdings (MEDP) Strong Earnings Outlook Means For Shareholders
Published . Updated .
This report does not map to a usual set of affected companies.
Directly affected
- MEDP Medpace Holdings+13.7% 11d
Named in this report.
Indirectly affected
- XLI Industrial Select Sector SPDR+0.2% 30d
Industrial Select Sector SPDR holds the industrials sector that Medpace Holdings belongs to, so it often moves with news about it.
- IQV IQVIA Holdings+3.6% 11d
IQVIA Holdings is a peer of Medpace Holdings in commercial physical and biological research; rivals often move on the same news.
- INCY Incyte
Incyte is a peer of Medpace Holdings in commercial physical and biological research; rivals often move on the same news.
- CRL Charles River Laboratories International+10.4% 13d
Charles River Laboratories International is a peer of Medpace Holdings in commercial physical and biological research; rivals often move on the same news.
- ICLR ICON Public-2.7% 16d
ICON Public is a peer of Medpace Holdings in commercial physical and biological research; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| MEDP | +3.82% | +6.25% | base | after close | after close | after close | after close |
| XLINo price data for this ticker | — | — | — | — | — | — | — |
| IQVNo price data for this ticker | — | — | — | — | — | — | — |
| INCYNo price data for this ticker | — | — | — | — | — | — | — |
| CRLNo price data for this ticker | — | — | — | — | — | — | — |
| ICLRNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
What Medpace Holdings (MEDP) Strong Earnings Outlook Means For Shareholders Simply Wall St
Source: Simply Wall St
This story
| Company | When | Move | Status |
|---|---|---|---|
| MEDP | three days earlier | +6.25% | final price |
| MEDP | five days earlier | +3.82% | final price |
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (jointly held), worth $15,001 - $50,000 on 14 Sep 2026. That is 47 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (held by a dependent child), worth $1,001 - $15,000 on 8 Sep 2026. That is 53 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 58 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Incyte (INCY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 57 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Charles River Laboratories International (CRL) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 36 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Icon (ICLR) (jointly held), worth $15,001 - $50,000 on 14 Aug 2026. That is 78 days before publication. Filed 1 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“What Medpace Holdings (MEDP) Strong Earnings Outlook Means For Shareholders” scores 12 out of 100. The score uses 1 sources.